Literature DB >> 22990404

Are catecholamine-derived indexes in adrenal venous sampling useful for judging selectivity and laterality in patients with primary aldosteronism?

Yasutaka Baba1, Sadao Hayashi, Masayuki Nakajo.   

Abstract

In order to investigate retrospectively whether catecholamine concentrations obtained by adrenal venous sampling (AVS) are useful for lateralization of the aldosteronoma-bearing adrenal gland. The study population comprised 35 patients (10 men, 25 women; mean age, 49.8 years) with aldosteronoma and 18 patients (9 men, 9 women; mean age, 51.8 years) with non-functioning adenoma who underwent AVS between 1994 and 2010. In all cases, AVS was performed without administering adrenocorticotrophic hormone. Successful or unsuccessful adrenal vein blood sampling (selectivity) was judged by the ratio of plasma cortisol (C) level in each adrenal vein to that in the infra-renal inferior vena cava [C(side)/C(IVC)] as a gold standard, with successful selectivity defined using four different cut-off values [C(side)/C(IVC) ≥ 3.0, 2.0, 1.36 or 1.1]. Receiver operating characteristics (ROC) analyses were conducted to determine: (1) degree of selectivity; and (2) the best catecholamine (epinephrine, norepinephrine, and dopamine)-derived index for lateralization of the aldosteronoma-bearing adrenal gland. Among the catecholamine-derived indexes, the epinephrine concentration ratio of adrenal vein to IVC was the most reliable for all four different cut-off values in the evaluation of adrenal vein selectivity. Meanwhile, the ratio of aldosterone to norepinephrine between dominant and non-dominant sides was the most reliable index (right: area under the curve (AUC), 0.965 ± 0.024; 95 % confidence interval (CI), 0.874-0.996; left: AUC, 0.937 ± 0.033; 95 % CI, 0.834-0.985) for lateralization of the aldosteronoma-bearing gland. Catecholamine concentrations obtained by AVS are useful for not only judging selectivity, but also lateralization of the aldosteronoma-bearing gland.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22990404     DOI: 10.1007/s12020-012-9793-x

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  22 in total

1.  A stress reaction affects assessment of selectivity of adrenal venous sampling and of lateralization of aldosterone excess in primary aldosteronism.

Authors:  Teresa M Seccia; Diego Miotto; Michele Battistel; Raffaella Motta; Marlena Barisa; Carmela Maniero; Achille C Pessina; Gian Paolo Rossi
Journal:  Eur J Endocrinol       Date:  2012-02-13       Impact factor: 6.664

2.  Role for adrenal venous sampling in primary aldosteronism.

Authors:  William F Young; Anthony W Stanson; Geoffrey B Thompson; Clive S Grant; David R Farley; Jon A van Heerden
Journal:  Surgery       Date:  2004-12       Impact factor: 3.982

3.  The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism.

Authors:  Gian Paolo Rossi; Marlena Barisa; Bruno Allolio; Richard J Auchus; Laurence Amar; Debbie Cohen; Christoph Degenhart; Jaap Deinum; Evelyn Fischer; Richard Gordon; Ralph Kickuth; Gregory Kline; Andre Lacroix; Steven Magill; Diego Miotto; Mitsuhide Naruse; Tetsuo Nishikawa; Masao Omura; Eduardo Pimenta; Pierre-François Plouin; Marcus Quinkler; Martin Reincke; Ermanno Rossi; Lars Christian Rump; Fumitoshi Satoh; Leo Schultze Kool; Teresa Maria Seccia; Michael Stowasser; Akiyo Tanabe; Scott Trerotola; Oliver Vonend; Jiri Widimsky; Kwan-Dun Wu; Vin-Cent Wu; Achille Cesare Pessina
Journal:  J Clin Endocrinol Metab       Date:  2012-03-07       Impact factor: 5.958

4.  Laparoscopic adrenalectomy: a new standard of care.

Authors:  H I Vargas; L R Kavoussi; D L Bartlett; J R Wagner; D J Venzon; D L Fraker; H R Alexander; W M Linehan; M M Walther
Journal:  Urology       Date:  1997-05       Impact factor: 2.649

Review 5.  Primary aldosteronism: from bench to bedside.

Authors:  Norlela Sukor
Journal:  Endocrine       Date:  2011-11-01       Impact factor: 3.633

6.  Medical management of aldosterone-producing adenomas.

Authors:  R P Ghose; P M Hall; E L Bravo
Journal:  Ann Intern Med       Date:  1999-07-20       Impact factor: 25.391

7.  Outcomes analysis in patients undergoing laparoscopic adrenalectomy for hormonally active adrenal tumors.

Authors:  L M Brunt; J F Moley; G M Doherty; T C Lairmore; M K DeBenedetti; M A Quasebarth
Journal:  Surgery       Date:  2001-10       Impact factor: 3.982

8.  Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines.

Authors:  G Eisenhofer; B Rundquist; A Aneman; P Friberg; N Dakak; I J Kopin; M C Jacobs; J W Lenders
Journal:  J Clin Endocrinol Metab       Date:  1995-10       Impact factor: 5.958

9.  Regional sources of free and sulfoconjugated catecholamines in hypertension.

Authors:  O Kuchel; N T Buu; P Roy; P Hamet; P Larochelle; J Genest
Journal:  Hypertension       Date:  1984 Mar-Apr       Impact factor: 10.190

Review 10.  Primary aldosteronism: an update on screening, diagnosis and treatment.

Authors:  Gian Paolo Rossi; Achille Cesare Pessina; Anthony M Heagerty
Journal:  J Hypertens       Date:  2008-04       Impact factor: 4.844

View more
  1 in total

Review 1.  Aldosterone excess and resistant hypertension: investigation and treatment.

Authors:  Michael Stowasser
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.